191 related articles for article (PubMed ID: 29906512)
1. Mechanisms of fibronectin-binding protein A (FnBPA
Zhang R; Li S; Zhang XK; Wang Y; Yang LY; Zeng H; Yan DP; Zou QM; Zuo QF
Clin Immunol; 2018 Sep; 194():1-8. PubMed ID: 29906512
[TBL] [Abstract][Full Text] [Related]
2. Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model.
Joshi A; Pancari G; Cope L; Bowman EP; Cua D; Proctor RA; McNeely T
Hum Vaccin Immunother; 2012 Mar; 8(3):336-46. PubMed ID: 22327491
[TBL] [Abstract][Full Text] [Related]
3. IL-17A plays an important role in protection induced by vaccination with fibronectin-binding domain of fibronectin-binding protein A against Staphylococcus aureus infection.
Narita K; Asano K; Nakane A
Med Microbiol Immunol; 2017 Jun; 206(3):225-234. PubMed ID: 28378247
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection.
Narita K; Hu DL; Asano K; Nakane A
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31358568
[TBL] [Abstract][Full Text] [Related]
5. Protective humoral and CD4
Yu W; Yao D; Yu S; Wang X; Li X; Wang M; Liu S; Feng Z; Chen X; Li W; Wang L; Liu W; Ma J; Yu L; Tong C; Song B; Cui Y
Sci Rep; 2018 Feb; 8(1):3580. PubMed ID: 29483570
[TBL] [Abstract][Full Text] [Related]
6. One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.
Mancini F; Monaci E; Lofano G; Torre A; Bacconi M; Tavarini S; Sammicheli C; Arcidiacono L; Galletti B; Laera D; Pallaoro M; Tuscano G; Fontana MR; Bensi G; Grandi G; Rossi-Paccani S; Nuti S; Rappuoli R; De Gregorio E; Bagnoli F; Soldaini E; Bertholet S
PLoS One; 2016; 11(1):e0147767. PubMed ID: 26812180
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models.
Yang L; Cai C; Feng Q; Shi Y; Zuo Q; Yang H; Jing H; Wei C; Zhuang Y; Zou Q; Zeng H
Sci Rep; 2016 Feb; 6():20929. PubMed ID: 26865417
[TBL] [Abstract][Full Text] [Related]
8. A Multiple Antigenic Peptide Mimicking Peptidoglycan Induced T Cell Responses to Protect Mice from Systemic Infection with Staphylococcus aureus.
Wang XY; Huang ZX; Chen YG; Lu X; Zhu P; Wen K; Fu N; Liu BY
PLoS One; 2015; 10(8):e0136888. PubMed ID: 26317210
[TBL] [Abstract][Full Text] [Related]
9. A novel bivalent fusion vaccine induces broad immunoprotection against Staphylococcus aureus infection in different murine models.
Yang L; Zhou H; Cheng P; Yang Y; Tong Y; Zuo Q; Feng Q; Zou Q; Zeng H
Clin Immunol; 2018 Mar; 188():85-93. PubMed ID: 29289748
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection.
Narita K; Hu DL; Asano K; Nakane A
Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25857736
[TBL] [Abstract][Full Text] [Related]
11. Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A.
Narita K; Hu DL; Mori F; Wakabayashi K; Iwakura Y; Nakane A
Infect Immun; 2010 Oct; 78(10):4234-42. PubMed ID: 20679443
[TBL] [Abstract][Full Text] [Related]
12. Induction of cell-mediated immunity to Staphylococcus aureus in the mouse mammary gland by local immunization with a live attenuated mutant.
Gómez MI; Sordelli DO; Buzzola FR; García VE
Infect Immun; 2002 Aug; 70(8):4254-60. PubMed ID: 12117934
[TBL] [Abstract][Full Text] [Related]
13. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms.
Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ
mBio; 2018 Oct; 9(5):. PubMed ID: 30327437
[No Abstract] [Full Text] [Related]
14. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice.
Lin L; Ibrahim AS; Xu X; Farber JM; Avanesian V; Baquir B; Fu Y; French SW; Edwards JE; Spellberg B
PLoS Pathog; 2009 Dec; 5(12):e1000703. PubMed ID: 20041174
[TBL] [Abstract][Full Text] [Related]
15. CD8α
Zhang W; Xu L; Zhang X; Xu J; Jin JO
Immunology; 2020 Apr; 159(4):404-412. PubMed ID: 31909831
[TBL] [Abstract][Full Text] [Related]
16. Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity.
Choi SJ; Kim MH; Jeon J; Kim OY; Choi Y; Seo J; Hong SW; Lee WH; Jeon SG; Gho YS; Jee YK; Kim YK
PLoS One; 2015; 10(9):e0136021. PubMed ID: 26333035
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death.
Nilsson IM; Patti JM; Bremell T; Höök M; Tarkowski A
J Clin Invest; 1998 Jun; 101(12):2640-9. PubMed ID: 9637697
[TBL] [Abstract][Full Text] [Related]
18. Identification of the immunodominant regions of Staphylococcus aureus fibronectin-binding protein A.
Zuo QF; Cai CZ; Ding HL; Wu Y; Yang LY; Feng Q; Yang HJ; Wei ZB; Zeng H; Zou QM
PLoS One; 2014; 9(4):e95338. PubMed ID: 24736634
[TBL] [Abstract][Full Text] [Related]
19. Role and plasticity of Th1 and Th17 responses in immunity to
Ferraro A; Buonocore SM; Auquier P; Nicolas I; Wallemacq H; Boutriau D; van der Most RG
Hum Vaccin Immunother; 2019; 15(12):2980-2992. PubMed ID: 31149870
[TBL] [Abstract][Full Text] [Related]
20. Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A.
Montgomery CP; Daniels M; Zhao F; Alegre ML; Chong AS; Daum RS
Infect Immun; 2014 May; 82(5):2125-34. PubMed ID: 24614654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
